Wade Walke | Vice President-Investor Relations |
Anne Wojcicki | Chief Executive Officer & Co-Founder |
Joe Selsavage | Interim Chief Financial Officer & Accounting Officer |
Kenneth Hillan | Chief Therapeutics Officer |
Tiago Fauth | Credit Suisse |
Steven Mah | Cowen |
Good day, and thank you for standing by. Welcome to the 23andMe's Fiscal Year 2023 Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.